Riccardo Mazza: Do Weight, BMI, and Renal Function Independently Predict Acute Events in NVAF Patients on DOACs?
Riccardo Mazza, Cardiology Resident at University Vita-Salute San Raffaele, shared a post on LinkedIn about a recent article and his colleagues co-authored, adding:
“DOACs: Not weight.
Not renal function.
It’s plasma levels.
In our latest research letter, we addressed a key clinical question:
Do weight, BMI, and renal function independently predict acute events in NVAF patients on DOACs?
Short answer: they do not – once drug exposure is accounted for.
Our findings suggest a mediated effect: renal function influences outcomes through modulation of DOAC plasma levels, rather than acting as an independent determinant.
Clinical implications:
Weight and renal function remain essential for dose selection.
However, when it comes to actual patient risk, the key determinant may be:
- true pharmacological exposure
In other words:
We dose based on patient characteristics – but outcomes are driven by drug levels.
Link to the Research Letter in the first comment.
Grateful to the entire team Cosmo Godino, Carlo Gaspardone, Anna Salerno, Massimo Slavich, Rachele Sena.”
Title: Beyond Weight and Renal Function: DOAC Plasma Levels Remain the Primary Determinant of Acute Outcomes—A Re-Analysis of the 4Levels Study
Authors: Riccardo Mazza, Carlo Gaspardone, Chiara Miranda, Sofia Di Bisceglie, Alessia Minerva, Rachele Sena, Gianmarco Cozzani, Anna Salerno, Michela Cera, Massimo Slavich, Leila Anna De Lorenzo, Giulio Leo, Giulia Nemola, Annalisa Fattorini, Luciano Crippa, Patrizia Della Valle, Alberto Margonato, Armando D’Angelo, Cosmo Godino
Read the Full Article on Clinical Therapeutics
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 14, 2026, 13:09Yan Leyfman: Rewriting Sickle Cell Disease Biology with CRISPR Technology
-
Apr 14, 2026, 13:01Shahzaib Maqbool: Preeclampsia Through a Hematology Lens
-
Apr 14, 2026, 12:46Rosa Hart: Inside Pediatric Stroke Recovery with Dr. Catherine Schuster
-
Apr 14, 2026, 12:39Gonzalo Ladreda: Innovation in Stroke Care Is About Timing, Integration, and Real-World Usability
-
Apr 14, 2026, 12:30Roy P.C. Kessels: Stroke’s Cognitive Impact on Young Adults Is Significant and Often Overlooked
-
Apr 14, 2026, 12:22Mehari Gebreyohanns: New Insights on Wake-Up Strokes from Emergency Settings in Texas and Louisiana
-
Apr 14, 2026, 12:08Enrico Ferro: Comparative Study Raises Questions on PFA Safety in AF at EHRA 2026
-
Apr 14, 2026, 11:39Prachi Patel: How B Vitamins and Large-Scale Research Are Shaping Stroke Prevention
-
Apr 14, 2026, 11:28Jamie Brannigan: Help Shape the Future of Brain-Computer Interfaces in Stroke and Neurological Care